Related Experiment Video
Updated: Feb 28, 2026

10:52
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
3.1K
Late-Onset Huntington's Disease: A Case Report and Literature Review
Carlos Gonçalves1, Ana Sofia Ferreira2, André Calheiros1
1Internal Medicine, Unidade Local de Saúde do Alto Minho (ULSAM) Hospital Conde de Bertiandos, Ponte de Lima, PRT.
Cureus
|February 27, 2026
Summary
Late-onset Huntington's disease (LoHD) can present atypically in older adults. This case highlights the importance of considering LoHD in elderly patients with chorea and cognitive decline, even without a family history.
Area of Science:
- Neurology
- Genetics
- Geriatrics
Background:
- Huntington's disease (HD) is a neurodegenerative disorder caused by CAG trinucleotide repeat expansion in the huntingtin (HTT) gene.
- Late-onset Huntington's disease (LoHD), presenting after age 60, is uncommon and diagnostically challenging.
- Typical HD onset is in mid-adulthood, but LoHD requires specific diagnostic consideration.
Related Concept Videos
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

